- We are the Pharma Journal directory
Abiomed (NASDAQ: ABMD) is a pioneering supplier of cutting-edge medical technology that supports circulation and oxygenation....
The history of pharmacy in Dresden has been shaped by APOGEPHA Arzneimittel GmbH as a traditional...
Our team of knowledgeable advisors is committed to ensuring that our clients are fully compliant at...
Aether quickly engineers enzymes on its cutting-edge platform, allowing our customers to produce complicated and unique...
By commercialising a Flat Panel X-ray Source (FPS) with a large number of individually programmable emitters...
Your full-service partner in the pharmaceutical sector is ARTESAN. high-quality, client-focused solutions and personalised customer service....
Elasmogen Ltd is a firm that creates and develops soloMERsTM, a new breed of therapeutic biologics,...
The global pharmaceutical and life science sectors get temperature-controlled containers from Tower Cold Chain. Since 2007,...
The leading global contract manufacturer and provider of development services for the pharmaceutical and healthcare sectors...
Privately held, USFDA-approved, and one of the world's fastest-growing pharmaceutical companies, Aavis Pharmaceuticals is situated in...
With a goal of transforming care for a patient population that is underserved and vulnerable, extending...
The services offered by Contract Manufacturing (CDMOs) are pre-formulation, formulation development, stability studies, method development, pre-clinical and Phase I clinical trial materials, late-stage clinical trial materials, registration batches, formal stability, scale-up, and commercial production, among others. CDMOs are contract manufacturers and provide development as a basic service.
A contract manufacturing organisation (CMO) creates a ready-to-use medicine. In contrast, a contract development and manufacturing organisation (CDMO) covers everything from pre-formulation and formulation development through clinical trials and production.
Because all services are handled in one place, the through-process dependability of a CDMO might be appealing. However, both organisations can efficiently and accurately incorporate new medication items into the pharmaceutical sector.